Company Filing History:
Years Active: 1993-1994
Title: The Innovative Contributions of Martha R. Heimann
Introduction
Martha R. Heimann is a notable inventor based in Durham, NC (US), recognized for her significant contributions to the field of psychopharmacology. With a total of four patents to her name, she has made strides in developing compounds that are useful in treating psychosis. Her work reflects a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Heimann's latest patents include innovative compounds such as penta and tetrasubstituted piperidines, which are designed to treat psychosis. These compounds are characterized by the formula: ##STR1##, where R.sup.1 can be hydrogen, lower-alkyl, or phenyl-lower-alkyl. Another significant patent involves substituted 3-piperidinealkanamines and alkanamides, which also aim to address psychosis, represented by the formula: ##STR1##, with R.sup.1 being lower-alkyl or phenyl-lower-alkyl.
Career Highlights
Throughout her career, Heimann has worked with reputable companies, including Sterling Winthrop Inc. and Sterling Winthrop Inc. Her experience in these organizations has contributed to her expertise in pharmaceutical development and innovation.
Collaborations
Heimann has collaborated with esteemed colleagues such as Diane L. DeHaven-Hudkins and John P. Mallamo. These partnerships have likely enriched her research and development efforts, fostering a collaborative environment for innovation.
Conclusion
Martha R. Heimann's work exemplifies the impact of innovative thinking in the pharmaceutical industry. Her patents and collaborations highlight her dedication to advancing treatments for psychosis, making her a significant figure in the field.